↓ Skip to main content

Dove Medical Press

Article Metrics

Influenza treatment and prophylaxis with neuraminidase inhibitors: a review

Overview of attention for article published in Infection and Drug Resistance, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#30 of 929)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
twitter
1 tweeter
patent
3 patents
facebook
1 Facebook page

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
86 Mendeley
Title
Influenza treatment and prophylaxis with neuraminidase inhibitors: a review
Published in
Infection and Drug Resistance, November 2013
DOI 10.2147/idr.s36601
Pubmed ID
Authors

Mark Holodniy, Amanda Kamali

Abstract

Influenza virus is a pathogen that causes morbidity and mortality worldwide. Whereas vaccination is important for prevention of disease, given its limitations, antiviral therapy is at the forefront of treatment and also plays a role in prevention. Currently, two classes of antiviral medications, the adamantanes and the neuraminidase inhibitors, are approved for treatment. Given the resistance patterns of circulating influenza, adamantanes are not recommended. Within the US, two neuraminidase inhibitors are currently approved for both treatment and prevention, while worldwide there are four available. In this review, we will briefly discuss the epidemiology and pathology of influenza and then discuss neuraminidase inhibitors: their mechanism of action, resistance, development, and future applications.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
United States 1 1%
Sudan 1 1%
Unknown 83 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 15%
Student > Master 12 14%
Student > Ph. D. Student 10 12%
Researcher 10 12%
Other 8 9%
Other 24 28%
Unknown 9 10%
Readers by discipline Count As %
Medicine and Dentistry 23 27%
Agricultural and Biological Sciences 19 22%
Biochemistry, Genetics and Molecular Biology 11 13%
Chemistry 6 7%
Immunology and Microbiology 4 5%
Other 10 12%
Unknown 13 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 November 2019.
All research outputs
#1,218,471
of 17,367,552 outputs
Outputs from Infection and Drug Resistance
#30
of 929 outputs
Outputs of similar age
#18,524
of 271,428 outputs
Outputs of similar age from Infection and Drug Resistance
#1
of 9 outputs
Altmetric has tracked 17,367,552 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 929 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,428 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them